The NIAMS Strategic Plan for FY 2025–2029 focuses on advancing therapy, fostering discoveries, supporting research infrastructure, and communicating health advances from the Director.

NIAMS Strategic Plan FY 2025–2029 advances research in arthritis, musculoskeletal, and skin diseases, focusing on innovation, equity, collaboration, and workforce diversity.

NIAMS, established in 1986, supports research on arthritis, musculoskeletal, and skin diseases, aiming for transformative research and equitable health outcomes.

NIAMS aims for advances in disease understanding, personalized treatments, data science, digital health, and addressing health disparities over the next five years.

NIAMS, part of NIH, supports research on arthritis, musculoskeletal, and skin diseases through extramural and intramural programs, advancing health via innovative treatments.

The NIAMS FY 2025–2029 Plan outlines 4 goals, 10 priorities, and a commitment to equitable research and workforce support to improve human health outcomes.

NIAMS focuses on advancing therapies, fostering discoveries, supporting research infrastructure, and sharing breakthroughs to improve health in its mission areas.

NIAMS encourages creative research on arthritis, musculoskeletal, and skin diseases, offering resources and priorities for scientists and collaborators to explore.

NIAMS supports research into molecular and cellular processes to understand disease mechanisms, including the role of sex differences and interactions in health and disease.

Regenerative medicine uses stem cells, biomaterials, and gene editing to restore musculoskeletal and skin tissues, with NIAMS advancing research and clinical applications.

NIAMS leverages AI/ML and data science to improve treatments, foster collaborations, ensure data stewardship, and advance patient-specific research and tools.

NIAMS explores how behaviors, environment, and the exposome affect disease onset, severity, and treatment, aiming to reduce health disparities and improve outcomes.

NIAMS focuses on translating discoveries into patient care, emphasizing equitable, innovative clinical trials, precision medicine, and strategies to reduce health disparities.

NIAMS aims to reduce health disparities.

NIAMS highlights community-identified needs, priorities, and resources to advance arthritis, musculoskeletal, and skin disease research and treatments.

NIAMS fosters biomedical innovation by supporting advanced models, diagnostic tools, and technologies to improve research and patient care in bone, joint, muscle, and skin diseases.

NIAMS promotes interdisciplinary research and partnerships, uniting diverse fields, NIH agencies, and communities to advance care for bone, joint, muscle, and skin diseases.

NIAMS fosters research careers and mentoring early-stage scientists advance its mission areas.

NIAMS advances bone, joint, muscle, and skin health by sharing research updates and collaborating with partners to inform and support affected communities.